These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 20332197)

  • 1. XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model.
    Owyang AM; Maedler K; Gross L; Yin J; Esposito L; Shu L; Jadhav J; Domsgen E; Bergemann J; Lee S; Kantak S
    Endocrinology; 2010 Jun; 151(6):2515-27. PubMed ID: 20332197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-fat-diet-induced remission of diabetes in a subset of K
    Yan Z; Shyr ZA; Fortunato M; Welscher A; Alisio M; Martino M; Finck BN; Conway H; Remedi MS
    Diabetes Obes Metab; 2018 Nov; 20(11):2574-2584. PubMed ID: 29896801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary Selenium Deficiency Partially Mimics the Metabolic Effects of Arsenic.
    Carmean CM; Mimoto M; Landeche M; Ruiz D; Chellan B; Zhao L; Schulz MC; Dumitrescu AM; Sargis RM
    Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overfeeding-Induced Obesity Mouse Model Reveals Necessity for Sin3a in Postnatal Peak β-Cell Mass Acquisition.
    Bartolomé A; Ravussin Y; Yu J; Ferrante AW; Pajvani UB
    Diabetes; 2022 Nov; 71(11):2395-2401. PubMed ID: 35944274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Episodic β-cell death and dedifferentiation during diet-induced obesity and dysglycemia in male mice.
    Tersey SA; Levasseur EM; Syed F; Farb TB; Orr KS; Nelson JB; Shaw JL; Bokvist K; Mather KJ; Mirmira RG
    FASEB J; 2018 May; 32(11):fj201800150RR. PubMed ID: 29812970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burdock miR8175 in diet improves insulin resistance induced by obesity in mice through food absorption.
    Song H; Shi H; Ji M; Ding J; Cong L; Chen S; Zhou J; Zha X; Ye J; Li R; Hou X; Mao S; Jiang X; Zhang W; Li J; Zhang Y
    iScience; 2024 May; 27(5):109705. PubMed ID: 38660399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gevokizumab on glycemia and inflammatory markers in type 2 diabetes.
    Cavelti-Weder C; Babians-Brunner A; Keller C; Stahel MA; Kurz-Levin M; Zayed H; Solinger AM; Mandrup-Poulsen T; Dinarello CA; Donath MY
    Diabetes Care; 2012 Aug; 35(8):1654-62. PubMed ID: 22699287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-1 signaling pathway, an important target for inflammation surrounding in myocardial infarction.
    Huang J; Kuang W; Zhou Z
    Inflammopharmacology; 2024 Apr; ():. PubMed ID: 38676853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of DPIE [2-(1,2-Diphenyl-1
    Lim J; Seong J; Jung S; Lee TH; Kim E; Lee S
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-1β in atherosclerotic vascular calcification: From bench to bedside.
    Shen J; Zhao M; Zhang C; Sun X
    Int J Biol Sci; 2021; 17(15):4353-4364. PubMed ID: 34803503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1beta promotes the age-associated decline of beta cell function.
    Böni-Schnetzler M; Méreau H; Rachid L; Wiedemann SJ; Schulze F; Trimigliozzi K; Meier DT; Donath MY
    iScience; 2021 Nov; 24(11):103250. PubMed ID: 34746709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 Innate Lymphoid Cells: Protectors in Type 2 Diabetes.
    Painter JD; Akbari O
    Front Immunol; 2021; 12():727008. PubMed ID: 34489979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer's Disease.
    Litwiniuk A; Bik W; Kalisz M; Baranowska-Bik A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole and Isolated Protein Fractions Differentially Affect Gastrointestinal Integrity Markers in C57Bl/6 Mice Fed Diets with a Moderate-Fat Content.
    Price TR; Baskaran SA; Moncada KL; Minamoto Y; Klemashevich C; Jayuraman A; Sucholdoski JS; Tedeschi LO; Steiner JM; Pillai SD; Walzem RL
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33920187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling adipose tissue inflammasome for type 2 diabetes mellitus treatment: Current perspective and translational strategies.
    Banerjee A; Singh J
    Bioeng Transl Med; 2020 May; 5(2):e10150. PubMed ID: 32440558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-29 promoted obesity-induced inflammation and insulin resistance.
    Lin TY; Chiu CJ; Kuan CH; Chen FH; Shen YC; Wu CH; Hsu YH
    Cell Mol Immunol; 2020 Apr; 17(4):369-379. PubMed ID: 31363171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1β Inhibition for Chronic Kidney Disease in Obese Mice With Type 2 Diabetes.
    Lei Y; Devarapu SK; Motrapu M; Cohen CD; Lindenmeyer MT; Moll S; Kumar SV; Anders HJ
    Front Immunol; 2019; 10():1223. PubMed ID: 31191559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of interleukin-1 in general pathology.
    Kaneko N; Kurata M; Yamamoto T; Morikawa S; Masumoto J
    Inflamm Regen; 2019; 39():12. PubMed ID: 31182982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet inflammation in type 2 diabetes.
    Böni-Schnetzler M; Meier DT
    Semin Immunopathol; 2019 Jul; 41(4):501-513. PubMed ID: 30989320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of exosomal miRNAs derived from subcutaneous and visceral adipose tissues: Determination of targets for the treatment of obesity and associated metabolic disorders.
    Yang Z; Wei Z; Wu X; Yang H
    Mol Med Rep; 2018 Sep; 18(3):3314-3324. PubMed ID: 30066923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.